This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
Taher Manaquibwala, Saurabh Karnawat, Ashar Iqbal Lodi, et. al./Surface Mould Brachytherapy in Recurrent Basal Cell Carcinoma of Ala of Nose: A Case Report/Indian J Canc Educ Res 2022;10(1):39-42.
Timeline
Received : October 12, 2021
Accepted : November 19, 2021
Published : June 05, 2022
Abstract
Basal cell carcinoma accounts for at least 32% of all cancers globally. Of skin cancers other than melanoma, about 80% are basal cell carcinomas. Basal cell carcinoma commonly presents as ulcerative lesions on the exposed parts of the face. Modalities for the treatment of basal cell carcinoma include surgical excision, cryotherapy, and radiotherapy. This article presents case report of a middle aged female with recurrent basal cell carcinoma of the ala of nose treated with surface mould brachytherapy
References
1. Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015 Jun 1;88(2):167-79.
2. Goldberg LH, Rubin HA. Management of basal cell carcinoma. Which option is best? Postgrad Med. 1989 Jan; 85(1):57-8, 61-3.
3. Hacker SM, Browder JF, Ramos-Caro FA. Basal cell carcinoma. Choosing the best method of treatment for a particular lesion. Postgrad Med. 1993 Jun;93(8):101-4, 106-8, 111.
4. Clark CM, Furniss M, Mackay-Wiggan JM. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol. 2014 Jul;15(3):197- 216.
6. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989 Apr;15(4):424-31.
7. Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules. Dermatol Surg. 1996 Oct;22(10):854-8.
8. Nordin P, Larkö O, Stenquist B. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery. Br J Dermatol. 1997 Feb;136(2):1803.
9. Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg. 2003 Jun;29(6):566-71.
10. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003412. doi: 10.1002/14651858. CD003412.pub2. Update in: Cochrane Database Syst Rev. 2020 Nov 17;11:CD003412.
11. Skowronek J. Brachytherapy in the treatment of skin cancer: an overview. Postepy Dermatol Alergol. 2015 Oct;32(5):362-7.
12. Casey S, Awotwi-Pratt J, Bahl G. Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience. Cureus. 2019 Dec 18;11(12):e6412.
13. Delishaj D, Rembielak A, Manfredi B, Ursino S, Pasqualetti F, Laliscia C, Orlandi F, Morganti R, Fabrini MG, Paiar F. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature. J Contemp Brachytherapy.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Taher Manaquibwala, Saurabh Karnawat, Ashar Iqbal Lodi, et. al./Surface Mould Brachytherapy in Recurrent Basal Cell Carcinoma of Ala of Nose: A Case Report/Indian J Canc Educ Res 2022;10(1):39-42.
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.